Skip to main content
. 2018 Oct 26;21(Suppl Suppl 8):e25187. doi: 10.1002/jia2.25187

Abstract P022 – Table 1. Individual subject blood and cerebrospinal fluid parameters at Week 8

Subject 1 2 3 4
CSF cenicriviroc concentration, ng/mL 0.82 0.40 0.24 (less than LLQ) 0.24 (less than LLQ)
Plasma cenicriviroc concentration, ng/mL 718.6 211.1 411.9 70.5
CSF: plasma cenicriviroc concentration ratio (%) 0.11 0.19 0.06 0.34
CSF albumin concentration, mg/mL 1070 453 374 202
Serum albumin concentration, g/L 38 42 40 40
CSF: serum albumin ratio 28.2 10.8 9.4 5.1
Antiretroviral therapy abacavir, lamivudine, raltegravir lamivudine, atazanavir, ritonavir tenofovir DF, emtricitabine, dolutegravir tenofovir DF, emtricitabine, raltegravir
Cenicriviroc dose 150 mg 50 mg 150 mg 150 mg

tenofovir DF = tenofovir disoproxil fumarate.